论文部分内容阅读
目的了解社区门诊苯二氮卓艹类药物(BZDs)使用现状及用药人群特征。方法 2012年1月至6月对上海某社区门诊处方BZDs的失眠居民进行自编问卷、阿森斯失眠量表及简易焦虑及抑郁症状筛查问卷调查。结果 281例BZDs用药者中,首次处方原因为医师建议占35.2%,自行配药占64.8%,大多数(92.9%)未在专科医师指导下用药;偶尔或短期服药16.7%,长期间断服药33.8%,长期连续服药49.5%,其中>65岁以上和AIS评分≥12分的失眠人群中长期连续服药的比例高(P<0.01);用药人群有抑郁、焦虑倾向的比例分别为65.5%、9.6%,在>65岁以上失眠人群中抑郁和焦虑评分以及在AIS评分≥12分和长期连续服药的失眠人群抑郁评分增高尤为明显(P<0.01)。结论社区门诊BZDs的使用存在不规范现象,用药人群抑郁、焦虑倾向的比例高,应引起高度重视。
Objective To understand the current situation of the use of benzodiazepine drugs (BZDs) in community clinics and the characteristics of drug users. Methods From January to June 2012, a questionnaire survey of insomnia residents in a community outpatient setting BZDs in Shanghai was conducted with self-compiled questionnaires, the Accent Insomnia Scale and Simplified Anxiety and Depression Symptom Checklist. Results Among the 281 patients with BZDs, the reasons for the first prescription were as follows: 35.2% for physicians, 64.8% for self-medication, most of whom (92.9%) did not receive medication under the guidance of a specialist; occasionally or short-term medication 16.7% (49.5%) for long-term continuous medication, among which insomnia patients> 65 years of age and AIS score≥12 points had a higher proportion of long-term continuous medication (P <0.01), and the percentage of patients with depression and anxiety was 65.5% and 9.6% , Depression and anxiety scores in insomnia> 65 years old and depression scores in insomnia population with AIS score> = 12 and long-term continuous medication were especially significant (P <0.01). Conclusions The use of community outpatient BZDs is not standardized, and the proportion of depression and anxiety in drug users should be high.